Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOlfox6”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Early research (Phase 1)Study completedNCT03343301
What this trial is testing

Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

Who this might be right for
Gastrointestinal CancerGastrointestinal Cancer MetastaticGastric Cancer
Five Prime Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT01926769
What this trial is testing

A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

Who this might be right for
Previously Treated Advanced Colorectal Cancer
Gachon University Gil Medical Center 2
Large-scale testing (Phase 3)Ended earlyNCT03654729
What this trial is testing

Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)

Who this might be right for
Colorectal CancerChemotherapy-induced Peripheral Neuropathy
Egetis Therapeutics 291
Large-scale testing (Phase 3)UnknownNCT00003260
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 109
Testing effectiveness (Phase 2)Ended earlyNCT01229111
What this trial is testing

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT01622543
What this trial is testing

Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Canadian Cancer Trials Group 109
Testing effectiveness (Phase 2)Ended earlyNCT01532804
What this trial is testing

2nd-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 83
Not applicableUnknownNCT01472601
What this trial is testing

A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile

Who this might be right for
Colon Cancer
Samsung Medical Center 2,660
Early research (Phase 1)Study completedNCT00387387
What this trial is testing

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Who this might be right for
Neoplasms, Colorectal
GlaxoSmithKline 50
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Testing effectiveness (Phase 2)Ended earlyNCT00832299
What this trial is testing

Neo-Adjuvant FOLFOX for Rectal Carcinoma

Who this might be right for
Rectal Neoplasms
Beth Israel Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT01111604
What this trial is testing

Ramucirumab or Icrucumab in Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Eli Lilly and Company 158
Testing effectiveness (Phase 2)Study completedNCT00851084
What this trial is testing

Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Sanofi 268
Large-scale testing (Phase 3)WithdrawnNCT00735241
What this trial is testing

FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaLiver Metastases
Sirtex Medical
Testing effectiveness (Phase 2)Study completedNCT00308516
What this trial is testing

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Who this might be right for
Rectal CancerCancer of the RectumColorectal Cancer
SCRI Development Innovations, LLC 66
Testing effectiveness (Phase 2)Study completedNCT00743678
What this trial is testing

Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis

Who this might be right for
Colorectal CancerUnresectable Liver Metastasis
Samsung Medical Center 73
Testing effectiveness (Phase 2)Study completedNCT04722133
What this trial is testing

Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy

Who this might be right for
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
Yonsei University 36
Early research (Phase 1)Not Yet RecruitingNCT07500298
What this trial is testing

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

Who this might be right for
Phase 1SAR445877FOlfox6+4 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT00881504
What this trial is testing

FOLFOX6 With Bevacizumab for Biliary System Carcinoma

Who this might be right for
Biliary Tract Cancer
Georgetown University 9
Large-scale testing (Phase 3)Ended earlyNCT00070122
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 2,200
Load More Results